0001144204-15-041402.txt : 20150707 0001144204-15-041402.hdr.sgml : 20150707 20150707171541 ACCESSION NUMBER: 0001144204-15-041402 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150707 ITEM INFORMATION: Other Events FILED AS OF DATE: 20150707 DATE AS OF CHANGE: 20150707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmatrix, Inc. CENTRAL INDEX KEY: 0001574235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461821392 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36199 FILM NUMBER: 15977188 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-2333 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Ruthigen, Inc. DATE OF NAME CHANGE: 20130411 8-K 1 v415042_8k.htm FORM 8-K

 


  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 7, 2015

 

PULMATRIX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-36199 46-1821392
(State of incorporation) (Commission File No.) (IRS Employer Identification No.)

 

99 Hayden Avenue, Suite 390

Lexington, MA 02421

(Address of principal executive offices) (Zip Code)

 

 

Registrant’s telephone number, including area code: (781) 357-2333

 

 

(Former name or former address, if changed since last report.)

 


 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Section 8 – Other Events

 

Item 8.01. Other Events.

 

On June 15, 2015, following the closing of the previously announced Agreement and Plan of Merger, dated March 13, 2015, by and among Pulmatrix, Inc., a Delaware corporation previously known as “Ruthigen, Inc.” (the “Company”), Ruthigen Merger Corp., a Delaware corporation and a wholly owned subsidiary of the Company, and Pulmatrix Operating Company, a Delaware corporation previously known as “Pulmatrix Inc.,” and the effectiveness of the Company’s 1-for-2.5 reverse stock split of its issued and outstanding shares of common stock, the Company had 14,515,673 shares of its common stock outstanding.

 

 

* * *

 

 
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PULMATRIX, INC.
     
     
Date: July 7, 2015 By: /s/ William Duke, Jr.
    William Duke, Jr.
    Chief Financial Officer